We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.47%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$405B
AUM Growth
+$3.26B
Cap. Flow
-$4.73B
Cap. Flow %
-1.17%
Top 10 Hldgs %
17.59%
Holding
10,501
New
1,231
Increased
3,688
Reduced
4,131
Closed
1,043

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.12B
2
AAPL icon
Apple
AAPL
+$1.08B
3
MSFT icon
Microsoft
MSFT
+$1.05B
4
NKE icon
Nike
NKE
+$1.03B
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$821M

Sector Composition

Rank Sector Weight
1 Technology 17.8%
2 Financials 8.25%
3 Healthcare 6.4%
4 Consumer Discretionary 5.85%
5 Communication Services 4.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RSPF icon
3376
Invesco S&P 500 Equal Weight Financials ETF
RSPF
$308M
$2.91M ﹤0.01%
47,504
+3,102
+7% +$191K
NMRA icon
3377
Neumora Therapeutics
NMRA
$296M
$2.91M ﹤0.01%
295,657
+270,376
+1,069% +$2.8M
GDV icon
3378
Gabelli Dividend & Income Trust
GDV
$2.67B
$2.91M ﹤0.01%
127,934
-2,658
-2% -$59.6K
DOL icon
3379
WisdomTree True Developed International Fund
DOL
$841M
$2.9M ﹤0.01%
57,271
-441
-0.8% -$22.8K
PBT
3380
Permian Basin Royalty Trust
PBT
$1.53B
$2.9M ﹤0.01%
257,502
-176,815
-41% -$2.15M
IBRX icon
3381
ImmunityBio
IBRX
$8.01B
$2.9M ﹤0.01%
458,255
-467,234
-50% -$3.08M
IGE icon
3382
iShares North American Natural Resources ETF
IGE
$770M
$2.89M ﹤0.01%
65,749
-1,225
-2% -$55K
LYG icon
3383
Lloyds Banking Group
LYG
$89.6B
$2.89M ﹤0.01%
1,057,595
-881,828
-45% -$2.37M
ARQT icon
3384
Arcutis Biotherapeutics
ARQT
$3.23B
$2.88M ﹤0.01%
309,571
-181,106
-37% -$1.64M
ETX
3385
Eaton Vance Municipal Income 2028 Term Trust
ETX
$199M
$2.88M ﹤0.01%
153,957
-50,373
-25% -$922K
LEN icon
3386
CALL
Lennar Class A
LEN
$20.6B
$2.88M ﹤0.01%
19,834
-30,990
-61% -$4.72M
EXLS icon
3387
EXL Service
EXLS
$5.33B
$2.88M ﹤0.01%
91,697
-104,528
-53% -$3.14M
SLF icon
3388
CALL
Sun Life Financial
SLF
$45.6B
$2.88M ﹤0.01%
58,690
FLO icon
3389
Flowers Foods
FLO
$1.51B
$2.87M ﹤0.01%
129,255
-34,763
-21% -$823K
SOXX icon
3390
CALL
iShares Semiconductor ETF
SOXX
$45.3B
$2.86M ﹤0.01%
11,608
+340
+3% +$77.8K
VCEL icon
3391
Vericel Corp
VCEL
$2.28B
$2.86M ﹤0.01%
62,327
-62,690
-50% -$2.96M
MOS icon
3392
CALL
The Mosaic Company
MOS
$7.17B
$2.86M ﹤0.01%
+98,800
New +$2.98M
NVO
3393
CALL
Novo Nordisk
NVO
$209B
$2.85M ﹤0.01%
20,000
-17,500
-47% -$2.32M
WBD icon
3394
CALL
Warner Bros
WBD
$67.7B
$2.84M ﹤0.01%
382,000
+21,500
+6% +$172K
MFA
3395
MFA Financial
MFA
$920M
$2.84M ﹤0.01%
266,822
-67,148
-20% -$723K
GSAT icon
3396
Globalstar
GSAT
$10.9B
$2.83M ﹤0.01%
168,737
-22,798
-12% -$411K
KFY icon
3397
Korn Ferry
KFY
$4.27B
$2.83M ﹤0.01%
42,217
-30,796
-42% -$1.98M
CTBI icon
3398
Community Trust Bancorp
CTBI
$1.4B
$2.83M ﹤0.01%
64,864
-8,670
-12% -$364K
KNF icon
3399
Knife River
KNF
$3.79B
$2.83M ﹤0.01%
40,304
-40,278
-50% -$3.01M
TILT icon
3400
FlexShares Morningstar US Market Factors Tilt Index Fund
TILT
$2.26B
$2.83M ﹤0.01%
14,139
-2
-0% -$391

Similar funds

UBS Group's Q2 2024 Portfolio in Review

As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

UBS Group's Q2 2024 filing shows 1,231 new, 3,688 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
  • UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
  • UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
  • UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
  • UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
  • UBS Group opened 1,231 new positions and closed 1,043 in Q2 2024.
  • UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.